Loading...





Recently Launched!
Check out Investor Copilot custom GPT, which lets you enjoy ChatGPT functionality with recent financial information
Conversationally interact with ChatGPT to now analyze updated prices, technical indicators, financial statements, macro-economic/company news & more for Stocks, ETFs & Cryptos

[ADAP] Adaptimmune Therapeutics plc - Cash Equivalents / Assets

Data updated 2024-Mar-23 (Saturday)

  Note: Detailed Statistics for Cash Equivalents / Assets in Balance Sheet for Adaptimmune Therapeutics plc [NASDAQ:ADAP] with frequency distribution chart that analyze trends & history . Cash Equivalents / Total Assets is expressed as a %. View Balance Sheet for broader context

Share       
 
        
 Select stock symbol (if different) and line item / metric for Statement type above & click View to see details
Quarterly Cash Equivalents / Assets values for Adaptimmune Therapeutics plc are rounded to enhance readability
   2023-Dec  2023-Sep  2023-Jun  2023-Mar  2022-Dec  2022-Sep
Cash Equivalents / Assets 52.0% 54.5% 59.7% 57.5% 62.2% 60.1%
Sequential Quarter Growth -4.6% -8.6% +3.8% -7.6% +3.5% -9.6%
Quarter-on Quarter Growth -16.4% -9.3% -10.2% -20.7% -21.0% -11.5%
Annual Cash Equivalents / Assets values for Adaptimmune Therapeutics plc are rounded to enhance readability
   2023-Dec  2022-Dec  2021-Dec  2020-Dec  2019-Dec  2018-Dec
Cash Equivalents / Assets 52.0% 62.2% 78.7% 81.6% 49.3% 74.1%
Year-on-Year Growth -16.4% -21.0% -3.6% +65.5% -33.5% +0.1%
2-yr CAGR -18.7% -12.7% +26.3% +4.9% -18.4% -2.1%
3-yr CAGR -14.0% +8.0% +2.0% +3.3% -13.9%
4-yr CAGR +1.3% -4.3% +1.5% +1.3%
5-yr CAGR -6.8% -3.4% +0.3%
Frequency distribution of quarterly Cash Equivalents / Assets values from 2015-Sep-30 grouped into buckets. Latest Cash Equivalents / Assets value is 52 as of 2023-Dec-31

Subsequent stock performance post earnings date till next announcement for Adaptimmune Therapeutics plc mapped with quarterly Cash Equivalents / Assets values reported at that time. Most recent value denoted with star


   
     
Select frequency and calculation type for Cash Equivalents / Assets above for vertical axis in scatter chart. Additionally choose type of performance for horizontal axis
Bayesian (Conditional Probability) analysis for Adaptimmune Therapeutics plc with subsequent post-earnings performance given Cash Equivalents / Assets values. Analysis uses quarterly data and subsequent absolute performance. Most recent quarter is denoted with a star and corresponding partial performance is excluded from calculations
   Underperform (absolute perf.)  Outperform (absolute perf.)
Cash Equivalents / Assets - Low 65% 35%
Cash Equivalents / Assets - Medium 38% 62%
Cash Equivalents / Assets - High 52% 48%
 
Cash Equivalents / Assets (Sequential growth %) - Low 56% 44%
Cash Equivalents / Assets (Sequential growth %) - Medium 31% 69%
Cash Equivalents / Assets (Sequential growth %) - High 61% 39%
 
Cash Equivalents / Assets (QoQ growth %) - Low 52% 48%
Cash Equivalents / Assets (QoQ growth %) - Medium 46% 54%
Cash Equivalents / Assets (QoQ growth %) - High 57% 43%
 


Related to Adaptimmune Therapeutics plc

Information for Adaptimmune Therapeutics plc

  Current Detail : Recent daily/monthly performance & benchmark comparison
  Historical Detail : Historical performance & related information using Time Machine
  Financial Statements : Analyze Income Statement, Balance Sheet & Cashflow Statement and also compare with peers Currently Viewing
  Bayesian Statement Classifier : Investigate historical financial statements to make probabalistic predictions using Artificial Intelligence
  Anomaly Detection : Investigate unusual recent performance & technicals with historical context using AI
  Historical Seasonality : Seasonal performance by calendar months
  Technical History : Popular Technical indicator trends (RSI, MACD etc.)
  Metric Deciles : Contextualizing recent performance & technical levels into historical decile buckets
  Dollar Cost Averaging : Dollar Cost Average (DCA) over time in your portfolio
  Moving Averages : Key Simple & Exponential Moving Averages
  Historical Analogues : Insights from closest historical matches to recent performance using Artificial Intelligence
  Chart Pattern Matching : Insights from similar historical charts to recent chart using Artificial Intelligence
  News Stories : News stories on 2024-Jun-14 on Google
  SEC Reports : Quarterly reports around 2024-Jun-14 on SEC Edgar

Compare Adaptimmune Therapeutics plc with other assets

  Market Performance : Recent performance across covered assets
  Historical Performance : Prior & Subsequent performance across assets on a historical date
  Market Technicals : Technical indicator levels across covered assets
  Market Seasonality : Seasonal performance by calendar months across covered assets
  Pair Correlations : Performance Correlations with other assets
  Beta : Volatility relative to the broad market
  Performance Comparison : Visually compare/benchmark performance with other assets over time
  Side-by-Side Comparison : Contrast with other assets over time in a side-by-side presentation
  Sector : Health Care sector performance which includes Adaptimmune Therapeutics plc
  Industry : Biotechnology industry performance which includes Adaptimmune Therapeutics plc










Ask brAIn  Experimental
  •  Hi! Ask me something. Use names or tickers to identify stock / etf / crypto symbols (e.g. aapl for Apple Inc.) . Click on below for examples of queries, list of special shortcuts & more